|
|
||||||||




Departments of
*
Molecular Biology and
Cell Signaling, DNAX Research Institute, Palo Alto, CA 94304; and
Department of Tumor Cell Biology, St. Jude Childrens Research Hospital, Memphis, TN 38105
We have previously reported that IL-10 inhibits proliferation of
normal bone marrow-derived macrophages and of the monocyte/macrophage
cell line J774. Activation of Stat3 was shown to be necessary and
sufficient to mediate inhibition of proliferation. To investigate
further the mechanism of growth arrest, we examined the effect of IL-10
on expression of cell cycle inhibitors. We found that IL-10 treatment
increases expression of the cyclin-dependent kinase inhibitors
p19INK4D and p21CIP1 in macrophages. IL-10
cannot induce p19INK4D expression or block proliferation
when Stat3 signaling is blocked by a dominant negative Stat3 or a
mutant IL-10R
which does not recruit Stat3 in J774 cells, whereas
p21CIP1 induction is not affected. An inducibly active
Stat3 (coumermycin-dimerizable Stat3-Gyrase B), which suppresses J774
cell proliferation, also induced p19INK4D expression.
Sequencing of the murine p19INK4D promoter revealed two
candidate Stat3 binding sites, and IL-10 treatment activated a reporter
gene controlled by this promoter. These data suggest that
Stat3-dependent induction of p19INK4D mediates inhibition
of proliferation. Enforced expression of murine p19INK4D
cDNA J774 cells significantly reduced their proliferation. Use of
antisense p19INK4D and analysis of
p19INK4D-deficient macrophages confirmed that
p19INK4D is required for optimal inhibition of
proliferation by IL-10, and indicated that additional IL-10 signaling
events contribute to this response. These data indicate that
Stat3-dependent induction of p19INK4D and Stat3-independent
induction of p21CIP1 are important components of the
mechanism by which IL-10 blocks proliferation in
macrophages.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |